SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-044639
Filing Date
2022-12-06
Accepted
2022-12-06 21:02:08
Documents
1
Period of Report
2022-12-02

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5653
  Complete submission text file 0001140361-22-044639.txt   7290
Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOW STREET CAMBRIDGE MA 02138
Business Address
Cherington Charles (Reporting) CIK: 0001448698 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11460 | Film No.: 221448981